Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001927648-25-000009
Filing Date
2025-09-23
Accepted
2025-09-23 19:55:57
Documents
1
Period of Report
2025-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1758671755.html 4  
1 FORM 4 wk-form4_1758671755.xml 4 4081
  Complete submission text file 0001927648-25-000009.txt   5612
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901
Business Address
Burkhart Erin (Reporting) CIK: 0001927648 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 251334961